Composition
- Active ingredients
- TREPROSTINIL 20MG/20ML (1MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TREPROSTINIL 100MG/20ML (5MG/ML) · SolutionNDA208276-003 · Discontinued
- TREPROSTINIL 20MG/20ML (1MG/ML) · SolutionThis page
- TREPROSTINIL 200MG/20ML (10MG/ML) · SolutionNDA208276-004 · Discontinued
- TREPROSTINIL 50MG/20ML (2.5MG/ML) · SolutionNDA208276-002 · Discontinued
- TREPROSTINIL 0.2MG/ML · InjectableNDA021272-007 · Discontinued
- TREPROSTINIL 20MG/ML · InjectableNDA021272-005 · Discontinued
- TREPROSTINIL 5MG/ML · InjectableNDA021272-003 · Prescription
- TREPROSTINIL 1MG/ML · InjectableNDA021272-001 · Prescription
- TREPROSTINIL 0.4MG/ML · InjectableNDA021272-008 · Prescription
- TREPROSTINIL 0.1MG/ML · InjectableNDA021272-006 · Discontinued
- TREPROSTINIL 10MG/ML · InjectableNDA021272-004 · Prescription
- TREPROSTINIL 2.5MG/ML · InjectableNDA021272-002 · Prescription
Official product information
At a glance
- Brand name
- Remodulin
- Active substance
- treprostinil
- Route
- Intravenous, Subcutaneous
- Dosage form
- Solution
- Applicant
- United Therap
- Status
- Discontinued
- FDA approval
- 30 Jul 2018
- Application
- NDA208276-001